| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.178 | 30.492 | 34.207 | 33.741 | 37.086 | 41.431 | 56.667 | 57.623 | 74.085 | 79.296 |
| Total Income - EUR | 26.178 | 30.492 | 34.207 | 33.741 | 37.086 | 41.431 | 56.667 | 57.785 | 74.097 | 79.296 |
| Total Expenses - EUR | 19.738 | 22.772 | 26.714 | 25.030 | 28.780 | 37.337 | 43.410 | 42.959 | 45.666 | 46.300 |
| Gross Profit/Loss - EUR | 6.440 | 7.720 | 7.492 | 8.711 | 8.306 | 4.094 | 13.256 | 14.826 | 28.430 | 32.996 |
| Net Profit/Loss - EUR | 5.655 | 7.193 | 7.150 | 8.376 | 7.935 | 3.833 | 12.813 | 14.453 | 27.704 | 30.663 |
| Employees | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mdc Medical Drugs Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 997 | 2.249 | 1.789 | 19.704 | 19.016 | 14.690 | 10.248 | 6.542 | 4.275 |
| Current Assets | 5.686 | 11.879 | 17.202 | 26.565 | 16.796 | 21.338 | 36.174 | 55.898 | 43.622 | 33.060 |
| Inventories | 0 | 0 | 922 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 989 | 979 | 136 | 31 | 951 | 1.934 | 3.703 | 4.349 | 7.156 | 8.430 |
| Cash | 4.696 | 10.900 | 16.143 | 26.534 | 15.845 | 19.404 | 32.472 | 51.549 | 36.466 | 24.629 |
| Shareholders Funds | 4.932 | 12.075 | 19.021 | 27.048 | 34.459 | 37.640 | 49.618 | 64.224 | 47.786 | 34.479 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 851 | 802 | 429 | 1.316 | 2.049 | 2.854 | 1.268 | 1.942 | 2.400 | 2.877 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mdc Medical Drugs Center Srl